Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Nanomedicine and Cerebral Palsy: New Perspectives and Causes for Cerebral Palsy

Ulrich Kutschera

It is a chronic childhood disorder with numerous possible causes. Injury to the developing brain during pregnancy or shortly after birth can cause the motor, sensory, and cognitive deficits associated with cerebral palsy. Even though the causes of cerebral palsy vary, neuroinflammation plays a critical role in the pathophysiology of brain injury. Cerebral palsy currently has no effective treatment. Nanomedicine provides a new avenue for research and development of treatments for brain injury that causes cerebral palsy. Dendrimers and other nanomaterials allow multiple drugs to be delivered precisely to the cells responsible for neuroinflammation and injury, reducing the number of injury-related pathways. Furthermore, these materials allow for the delivery of agents that promote brain repair and regeneration, reducing injury and facilitating normal growth. The most recent advances in nanotechnology for the treatment of brain injuries, with a focus on cerebral palsy, are discussed. Possible future directions for making clinical translation easier for children and newborns are also discussed.